Download (PDF, 1.19MB) Category: Editorial Calendar 201813th October 2017Post navigationPreviousPrevious post:MC2 Therapeutics A/S Announces First Patient Dosed in Pivotal US Phase 3 Trial in Psoriasis VulgarisNextNext post:Media Information 2018